Eric's employment at NIST began with the investigation of changes in human serum albumin in response to ischemic episodes in order to determine specific analytes for measurement. Further protein-related research has focused on the development of affinity techniques to quantify low-abundance proteins in human serum with higher-order methods. He has also performed measurements in serum of additional analytes including glucose and vitamin B6.